Literature DB >> 1973607

Interleukin-2 receptor expression and interleukin-2 production in bullous pemphigoid.

J Schaller1, T Giese, M Ladusch, U F Haustein.   

Abstract

Expression of interleukin-2 (IL2) receptors was studied on peripheral blood lymphocytes (PBLs) in 25 patients with bullous pemphigoid. Analysis was carried out by flow cytometry. Without immunosuppressive therapy expression of IL2 receptors only on T cells (CD5) was significantly increased as shown by double staining (11.9% +/- 7.8% vs 2.1% +/- 1% in controls). After 2-3 weeks under immunosuppressive treatment with prednisolone and azathioprine, however, BP lymphocytes did not exhibit any IL2 receptors. PBLs of 18 BP patients showed an increase in IL2 production (1027.4 +/- 670.5 U/ml vs 270 +/- 100 U/ml in controls) during the acute stage of the disease after stimulation with phytohaemagglutinin (PHA)/phorbol myristate acetate (PMA). On the contrary, IL2 production of the same cells in five patients was only in the lowest range of control values after PHA stimulation without PMA (12.5 +/- 29.6 U/ml vs 40 +/- 20 U/ml in controls). Under treatment with immunosuppressants the IL2 production normalized after PHA/PMA stimulation and slightly decreased following PHA stimulation. From these results we conclude that a T-cell activation via activation antigens, as IL2 receptors, and the production of the specific ligand, IL2, may play a role in the pathogenesis of bullous pemphigoid, especially in the earliest stages, and serve as a marker of disease activity.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1973607     DOI: 10.1007/bf00371640

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  20 in total

1.  An eosinophil chemotactic factor present in blister fluids of bullous pemphigoid patients.

Authors:  T Baba; H Sonozaki; K Seki; M Uchiyama; Y Ikesawa; M Toriisu
Journal:  J Immunol       Date:  1976-01       Impact factor: 5.422

2.  [The behavior of membrane receptors of peripheral blood lymphocytes in bullous pemphigoid].

Authors:  J Schaller; U F Haustein
Journal:  Hautarzt       Date:  1989-05       Impact factor: 0.751

3.  [Status of immunity in bullous pemphigoid].

Authors:  I Lohrisch; K Herrmann; U F Haustein
Journal:  Dermatol Monatsschr       Date:  1979-12

Review 4.  Transmembrane signals in the activation of T lymphocytes by mitogenic antigens.

Authors:  J W Hadden
Journal:  Immunol Today       Date:  1988 Jul-Aug

5.  Serologic cross-reactivity of T11 target structure and lymphocyte function-associated antigen 3. Evidence for structural homology of the sheep and human ligands of CD2.

Authors:  G Tiefenthaler; M L Dustin; T A Springer; T Hünig
Journal:  J Immunol       Date:  1987-10-15       Impact factor: 5.422

6.  An alternative pathway of T-cell activation: a functional role for the 50 kd T11 sheep erythrocyte receptor protein.

Authors:  S C Meuer; R E Hussey; M Fabbi; D Fox; O Acuto; K A Fitzgerald; J C Hodgdon; J P Protentis; S F Schlossman; E L Reinherz
Journal:  Cell       Date:  1984-04       Impact factor: 41.582

7.  Lymphotoxin detected in the blister fluid of bullous pemphigoid patients.

Authors:  E W Jeffes; R S Yamamoto; A R Ahmed; G A Granger
Journal:  J Clin Immunol       Date:  1984-01       Impact factor: 8.317

8.  Identification of chemoattractant activity for lymphocytes in blister fluid of patients with bullous pemphigoid: evidence for the presence of a lymphokine.

Authors:  D M Center; B U Wintroub; K F Austen
Journal:  J Invest Dermatol       Date:  1983-09       Impact factor: 8.551

9.  Suppressor cell function is preserved in pemphigus and pemphigoid.

Authors:  A J King; S A Schwartz; D Lopatin; J J Voorhees; L A Diaz
Journal:  J Invest Dermatol       Date:  1982-09       Impact factor: 8.551

10.  Early steps of lymphocyte activation bypassed by synergy between calcium ionophores and phorbol ester.

Authors:  A Truneh; F Albert; P Golstein; A M Schmitt-Verhulst
Journal:  Nature       Date:  1985 Jan 24-30       Impact factor: 49.962

View more
  5 in total

Review 1.  Bullous pemphigoid: from bench to bedside.

Authors:  Scott R A Walsh; David Hogg; P Régine Mydlarski
Journal:  Drugs       Date:  2005       Impact factor: 9.546

2.  Detection of elevated levels of IL-4, IL-6, and IL-10 in blister fluid of bullous pemphigoid.

Authors:  E Schmidt; B Bastian; R Dummer; H P Tony; E B Bröcker; D Zillikens
Journal:  Arch Dermatol Res       Date:  1996-06       Impact factor: 3.017

3.  The interleukin-2 receptor in lesions and serum of bullous pemphigoid.

Authors:  D Zillikens; A Ambach; M Schuessler; R Dummer; A A Hartmann; G Burg
Journal:  Arch Dermatol Res       Date:  1992       Impact factor: 3.017

4.  Expression of the JAK/STAT Signaling Pathway in Bullous Pemphigoid and Dermatitis Herpetiformis.

Authors:  K Juczynska; A Wozniacka; E Waszczykowska; M Danilewicz; M Wagrowska-Danilewicz; J Wieczfinska; R Pawliczak; A Zebrowska
Journal:  Mediators Inflamm       Date:  2017-10-24       Impact factor: 4.711

5.  A new eruption of bullous pemphigoid within psoriatic plaques following cyclosporine withdrawal.

Authors:  Katerina Svigos; Lauren Fried; Lu Yin; Nooshin Brinster; Kristen Lo Sicco; Prince Adotama
Journal:  JAAD Case Rep       Date:  2020-12-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.